GM1 IgG Autoantibodies

Use: The BUHLMANN™ Anti-GM1 IgG ELISA is intended for the qualitative determination of human IgG autoantibodies directed against monosialotetrahexosylganglioside (GM1) in human serum.1

Limitations: This test was developed and its performance characteristics determined by Labcorp. It has not been cleared or approved by the Food and Drug Administration.

Methodology: Enzyme Linked Immunoassay (ELISA) for IgG antibodies to the ganglioside GM1

Lipemic samples can be avoided by having the patient fast for 12 hours prior to collection.